Product

TREATMENT STRATEGIES FOR COPD EXACERBATION PREVENTION: NEW EVIDENCE   Free to Public

Product Code: NOVAGCOPD
Free Supported Non-CME Special Features  2016  Best of ATS Conferences 

CLICK TO VIEW PACKAGE CONTENT - This Package has 1 Sessions

During this Novartis supported industry theater, a faculty of world-renowned experts explored the burden of COPD exacerbations and new evidence for exacerbation prevention in high-risk patients with dual bronchodilator indacaterol/glycopyrronium. The potential implications of these data on the position of dual bronchodilators in COPD management were also explored.
 


   
go to top